Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective/background: To assess whether cerebral structural alterations in isolated rapid eye movement sleep behavior disorder (iRBD) are progressive and differ from those of normal aging and whether they are related to clinical symptoms.
Patients/methods: In a longitudinal study of 18 patients with iRBD (age, 66.1 ± 5.7 years; 13 males; follow-up, 1.6 ± 0.6 years) and 24 age-matched healthy controls (age, 67.0 ± 4.9 years; 12 males; follow-up, 2.0 ± 0.9 years), all participants underwent multiple extensive clinical examinations, neuropsychological tests, and magnetic resonance imaging at baseline and follow-up. Surface-based cortical reconstruction and automated subcortical structural segmentation were performed on T1-weighted images. We used mixed-effects models to examine the differences between the groups and the differences in anatomical changes over time.
Results: None of the patients with iRBD demonstrated phenoconversion during the follow-up. Patients with iRBD had thinner cortices in the frontal, occipital, and temporal regions, and more caudate atrophy, compared to that in controls. In similar regions, group-by-age interaction analysis revealed that patients with iRBD demonstrated significantly slower decreases in cortical thickness and caudate volume with aging than that observed in controls. Patients with iRBD had lower scores on the Korean version of the Mini-Mental Status Examination ( = 0.037) and frontal and executive functions ( = 0.049) at baseline than those in controls; however, no significant group-by-age interaction was identified.
Conclusion: Patients with iRBD show brain atrophy in the regions that are overlapped with the areas that have been documented to be affected in early stages of Parkinson's disease. Such atrophy in iRBD may not be progressive but may be slower than that in normal aging. Cognitive impairment in iRBD is not progressive.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11094219 | PMC |
| http://dx.doi.org/10.3389/fnins.2024.1365307 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Abnormal theta- and gamma-band cortical activities during visuospatial attention in idiopathic REM sleep behavior disorder patients.
Biomed Eng Lett
September 2025
Department of Biomedical Engineering, College of Health Science, Yonsei University, Wonju, South Korea.
Unlabelled: Purpose: Idiopathic rapid eye movement (REM) sleep behavior disorder (iRBD) is a sleep disorder considered to be a prodromal stage of neurodegeneration disease and is often accompanied by cognitive impairments. The purpose of this study was to investigate spatiotemporal characteristics of abnormal oscillatory cortical activity associated with dysfunction of visuospatial attention in iRBD based on an explainable machine learning approach. Methods: EEGs were recorded from 49 iRBD patients and 49 normal controls while they were performing Posner's cueing task and transformed to cortical current density time-series.
View Article and Find Full Text PDFClinical and Biofluid Biomarkers of Sleep Dysfunction in Parkinson's Disease.
Sleep Med Clin
September 2025
Centre for Neurology, Academic Specialist Centre, Stockholm Health Services, Solnavägen 2, 11365 Stockholm, Sweden; Department of Clinical Neuroscience, Karolinska Institutet, 17177 Stockholm, Sweden; Department of Neurology, Karolinska University Hospital, Bioclinicum J5:20, Stockholm 17164, Swede
Parkinson's disease is a neurodegenerative disorder with an increasing prevalence worldwide. The development of disease-modifying therapies remains a critical priority; however, early intervention is limited by the paucity of robust biomarkers for the prodromal stage. Sleep disturbances-particularly isolated rapid eye movement sleep behavior disorder (iRBD)-are emerging as key clinical markers of prodromal synucleinopathy, offering opportunities for early detection and risk stratification.
View Article and Find Full Text PDFFunctional Magnetic Resonance Imaging (fMRI) Signatures of Progression and Phenoconversion in Prodromal Synucleinopathies.
Mov Disord
September 2025
Central Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Background: Isolated rapid eye movement (REM) sleep behavior disorder (iRBD) is a prodromal manifestation of synucleinopathies and provides a critical window to identify early markers of progression to Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Time-averaged (static) and time-varying (dynamic) functional connectivity between large-scale brain networks may sensitively capture early pathophysiological changes and offer prognostic value beyond structural imaging.
Objectives: To use functional magnetic resonance imaging (fMRI) on a longitudinal iRBD cohort to assess alterations in static and dynamic functional connectivity and explore their relationship with disease conversion and regional neurotransmitter density.
Motor features that distinguish isolated REM sleep behavior disorder patients from healthy controls: A systematic review.
J Parkinsons Dis
September 2025
Department of Kinesiology and Health Sciences, University of Waterloo, Waterloo, Ontario, Canada.
Individuals with isolated REM sleep behavior disorder (iRBD) are at high risk of developing α-synucleinopathies, particularly Parkinson's disease (PD) and dementia with Lewy bodies (DLB). With the development of potential neuroprotective treatments for synucleinopathies, including PD, identifying clinical features that can allow for tracking subtle changes in prodromal disease and thereby monitoring risk of phenoconversion in iRBD is paramount. Subtle motor deficits have been suggested to be present in iRBD, making them potentially important clinical markers for predicting future phenoconversion.
View Article and Find Full Text PDFPlasma Neurofilament Light Chain and TNF-α Correlate with Motor Features in Isolated REM Sleep Behavior Disorder.
Mov Disord Clin Pract
July 2025
Centre for Preventive Neurology, Charterhouse Square, Queen Mary University of London, London, UK.
Background: Isolated RBD (iRBD) is a prominent early marker of Parkinson's disease and related disorders.
Objectives: Evaluate biomarkers of inflammation and axonal damage people with iRBD for disease progression.
Methods: Plasma samples from 27 video-polysomnography confirmed iRBD patients and 25 controls were analyzed for inflammatory biomarkers (CRP, IL-6, TNF-α, IFN-γ, IL-1β) and NfL using the Meso Scale Discovery platform.